Middle East Respiratory Syndrome (MERS) is a severe respiratory illness caused by MERS-CoV, first identified in Saudi Arabia in 2012. With a mortality rate of approximately 35%, it ranks among the most lethal respiratory viruses known. Symptoms range from mild flu-like illness to severe pneumonia and respiratory failure, and a significant proportion of cases are asymptomatic, making clinical diagnosis alone unreliable. The absence of early, accurate detection creates serious risks for healthcare settings and communities where the virus can spread undetected.
The MERS-Q Real-Time PCR Kit from Genes2Me delivers sensitive, specific detection of MERS-CoV RNA in a single-tube assay. It detects viral RNA directly from nasopharyngeal and oropharyngeal swabs collected in VTM, providing dependable results quickly to support timely clinical decisions and effective outbreak containment.
Genes2Me is a CE Marked molecular diagnostics company trusted by clinical laboratories across global markets. The MERS-Q Kit meets European conformity standards for in vitro diagnostic devices, validated to international benchmarks for accuracy, reliability, and safety.
The MERS-Q kit uses a single-tube real-time RT-PCR design with MERS-specific primers and fluorescent probes for accurate target detection. MERS-CoV RNA is detected in the FAM channel, while the HEX channel monitors an internal control to validate extraction and amplification in every run. Positive and no-template controls are included to guarantee assay accuracy and eliminate contamination risks across all workflows.
MERS-CoV infections frequently present with non-specific symptoms indistinguishable from other respiratory illnesses, and asymptomatic transmission adds further diagnostic complexity. Multiplex testing with a built-in internal control enables simultaneous pathogen detection and run validation, reducing false negatives and ensuring accurate, timely identification. In a disease with a 35% mortality rate, the cost of a missed diagnosis is too high to leave to clinical judgement alone.
Simultaneously detects MERS-CoV RNA (FAM) and validates the run via internal control (HEX), ensuring reliable results even under challenging laboratory conditions.
Detects viral RNA at very low concentrations, enabling confident identification in early-stage, low-titre, and asymptomatic infections.
Both controls are supplied in every kit, guaranteeing assay accuracy and eliminating contamination risks.
Validated on RapiCycler 96, Bio-Rad CFX96, QuantStudio 5, and LightCycler 480.
Carefully formulated reagents and optimised reaction conditions minimise preparation time and reduce the potential for procedural errors.
Consistent, trustworthy results support reliable clinical decision-making and seamless integration into existing laboratory workflows.
| Commercial Name | Old Cat No. | New Cat No. | Pack Size |
|---|---|---|---|
| MERS-Q Real Time PCR Kit | G2M802121R | 50 Tests |
Since its inception in 2016, Genes2me has been constantly striving towards setting a benchmark in the diagnostics space by introducing premium quality (Made in India) diagnostic kits which are CE-IVD, ISO-13485:2016, and ISO 9001:2015 certified, assuring our clients of unparalleled quality and compliance with international standards.
© 2025 Genes2me. All rights reserved.
